Heartflow (NASDAQ:HTFL) Stock Price Target Raised at Robert W. Baird

Heartflow (NASDAQ:HTFL) had its price objective hoisted by Robert W. Baird from $56.00 to $68.00 in a research note released on Friday,Benzinga reports. Robert W. Baird currently has an outperform rating on the stock.

Several other research firms have also commented on HTFL. UBS Group started coverage on shares of Heartflow in a research report on Wednesday, September 9th. They set a “neutral” rating and a $55.00 price objective for the company. Stifel Nicolaus lifted their price objective on shares of Heartflow from $40.00 to $45.00 and gave the stock a “buy” rating in a research note on Friday, August 14th. Canaccord Genuity Group boosted their target price on shares of Heartflow from $45.00 to $56.00 and gave the stock a “buy” rating in a report on Tuesday, September 22nd. Wall Street Zen cut shares of Heartflow from a “buy” rating to a “hold” rating in a research report on Saturday, November 7th. Finally, Wells Fargo & Company increased their price target on shares of Heartflow from $37.00 to $39.00 and gave the company an “overweight” rating in a report on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $60.12.

Heartflow Price Performance

NASDAQ:HTFL opened at $48.46 on Friday. The company has a market cap of $4.21 billion, a price-to-earnings ratio of -52.67 and a beta of 2.50. Heartflow has a 1 year low of $20.13 and a 1 year high of $60.65. The stock’s 50 day simple moving average is $51.91 and its two-hundred day simple moving average is $35.23.

Heartflow (NASDAQ:HTFL) last posted its earnings results on Thursday, November 12th. The company reported ($0.03) EPS for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.15. Heartflow had a negative return on equity of 20.42% and a negative net margin of 33.11%. The firm had revenue of $72.86 million during the quarter. During the same quarter in the prior year, the company posted ($0.27) earnings per share. As a group, analysts anticipate that Heartflow will post -0.75 EPS for the current year.

Insider Activity at Heartflow

In other Heartflow news, CEO John Farquhar sold 38,900 shares of Heartflow stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $55.74, for a total transaction of $2,168,286.00. Following the completion of the transaction, the chief executive officer directly owned 251,983 shares of the company’s stock, valued at $14,045,532.42. The trade was a 13.37% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Campbell Rogers sold 23,933 shares of the business’s stock in a transaction on Thursday, October 22nd. The shares were sold at an average price of $55.01, for a total transaction of $1,316,554.33. Following the transaction, the insider owned 73,453 shares in the company, valued at $4,040,649.53. This trade represents a 24.58% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 332,403 shares of company stock worth $16,602,786. Company insiders own 7.70% of the company’s stock.

Institutional Investors Weigh In On Heartflow

Several institutional investors have recently made changes to their positions in HTFL. XXEC Inc. purchased a new stake in Heartflow in the 2nd quarter worth about $2,524,764,000. BlackRock Inc. purchased a new position in shares of Heartflow during the second quarter valued at approximately $152,502,000. Bamco Inc. NY bought a new position in shares of Heartflow during the second quarter valued at approximately $94,625,000. Jupiter Topco LLC bought a new position in shares of Heartflow during the second quarter valued at approximately $70,983,000. Finally, Janus Henderson Group PLC raised its holdings in shares of Heartflow by 152.0% in the first quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock worth $53,063,000 after buying an additional 1,315,416 shares during the period.

Heartflow News Roundup

These are some of the HTFL news items that stood out recently:

• Positive Sentiment: Heartflow raised its 2026 revenue guidance to $262 million–$264 million, above the approximately $248.5 million consensus, signaling stronger expected growth. Financial results and guidance
• Positive Sentiment: Wells Fargo, Canaccord Genuity, Stifel and Baird raised their price targets to $68–$70 and maintained positive ratings, reflecting improved analyst expectations. Wells Fargo rating Canaccord Genuity rating Stifel rating Baird rating
• Negative Sentiment: A report said Heartflow’s CEO sold about $2.17 million worth of stock. Insider selling can concern investors, though the report alone does not establish the reason for the sale. CEO stock sale

About Heartflow

HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.